Attached files

file filename
10-Q - QUARTERLY REPORT - Sanara MedTech Inc.wndm_10q.htm
EX-31.2 - CERTIFICATION - Sanara MedTech Inc.wndm_ex312.htm
EX-32.1 - CERTIFICATION - Sanara MedTech Inc.wndm_ex321.htm
EX-31.1 - CERTIFICATION - Sanara MedTech Inc.wndm_ex311.htm
EXCEL - IDEA: XBRL DOCUMENT - Sanara MedTech Inc.Financial_Report.xls
EXHIBIT 32.2
 
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
IN ACCORDANCE WITH 18 U.S.C. SECTION 1350,
AS ADOPTED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of Wound Management Technologies, Inc. on Form 10-Q for the period ending March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof, I, Darren Stine, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 15, 2014
/s/ Darren E. Stine
Darren E. Stine
Chief Financial Officer